Kisspeptin-10 testing round-up: what our latest samples measured
What the published research on Kisspeptin-10 does and does not establish.
Testing ReportKisspeptin-10
Also known as: KP-10, Metastin
Moderate evidence
ClassHypothalamic neuropeptide fragment
Research statusPhase 2 clinical trials
Independent tests0
Studies indexed0
Overview
An upstream regulator of GnRH release, studied in reproductive endocrinology and in hypoactive sexual desire.
Kisspeptin-10 is classified as a hypothalamic neuropeptide fragment. Its current development status is: phase 2 clinical trials. Human trial data exists but is limited in size, duration or independence; conclusions should be held loosely.
The Peptide Institute tracks Kisspeptin-10 because it is actively sold through research-compound and telehealth channels. Our interest is narrow and specific: what is actually in the vial, whether the label is accurate, and whether the sellers of it can document what they claim. We take no position on whether anyone should use it.
Latest Coverage
Free download
Get the free Peptide Playbook, plus new breakthroughs as they happen.
What peptides are, why people are using them, and what results people are talking about, in plain English. Sign up and we email you the Playbook right away.
- The Peptide Playbook, free in your inbox
- Occasional updates on new developments
- No spam, unsubscribe anytime